Back to search
Catecholamine-resistant Hypotension (CRH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Catecholamine-resistant Hypotension (CRH) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Catecholamine-resistant Hypotension (CRH) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The objective of this study is to evaluate the effect of LJPC-501 infusion on mean arterial pressure (MAP) as assessed by standard of care vasopressor dose redu…
The objective of this study is to evaluate the effect of LJPC-501 infusion on mean arterial pressure (MAP) or reduction in sum norepinephrine (NE) equivalent do…
This is a Phase 3, double-blind, randomized study of LJPC-501 (angiotensin II) in adult patients diagnosed with catecholamine-resistant hypotension (CRH) conduc…
The primary objective of the study is to provide access to LJPC-501 for distributive shock patients who remain hypotensive despite receiving fluid and vasopress…